ACM
TARA icon

ADAR1 Capital Management’s Protara Therapeutics TARA Stock Holding History

ADAR1 Capital Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59M Hold
940,512
– – 0.16% 120
2026
Q1 		$4.9M Sell
940,512
-196,287
-17% -$1.16M 0.29% 77
2025
Q4 		$6.06M Buy
1,136,799
+1,101,576
+3,127% +$6.12M 0.45% 50
2025
Q3 		$153K Sell
35,223
-87,467
-71% -$283K 0.01% 189
2025
Q2 		$372K Hold
122,690
– – 0.06% 129
2025
Q1 		$523K Hold
122,690
– – 0.1% 101
2024
Q4 		$648K Buy
+122,690
New +$396K 0.13% 103
2024
Q2 		– Sell
-2,000
Closed -$8.02K – 313
2024
Q1 		$8.02K Sell
2,000
-194
-9% -$626 ﹤0.01% 233
2023
Q4 		$4.11K Buy
+2,194
New +$3.23K ﹤0.01% 151

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

ADAR1 Capital Management's TARA Position: Q2 2026 in Review

ADAR1 Capital Management held its Protara Therapeutics (TARA) position steady in Q2 2026 at 940,512 shares worth $3.59M. The position accounts for 0.16% of the portfolio, ranked #120.

ADAR1 Capital Management first reported a position in TARA in Q4 2023 and has held it in 9 quarters since. The position peaked at $6.06M in Q4 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • ADAR1 Capital Management held 940,512 shares of Protara Therapeutics worth $3.59M as of Q2 2026.
  • ADAR1 Capital Management left its Protara Therapeutics share count unchanged in Q2 2026.
  • Protara Therapeutics made up 0.16% of ADAR1 Capital Management's portfolio in Q2 2026, its #120 holding.
  • ADAR1 Capital Management first reported a position in Protara Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • ADAR1 Capital Management's Protara Therapeutics position peaked at $6.06M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.